Literature DB >> 15908286

Role of NMDA receptors in development of respiratory control.

Karen A Waters1, Rita Machaalani.   

Abstract

The N-methyl-D-aspartate (NMDA) receptor has many functions throughout the central nervous system (CNS) including its role within the centers controlling respiration. Although NMDA receptors are important for normal breathing, they are specifically active under conditions of stress, such as hypoxia. Consistent with its role in other neurological functions, the NMDA receptor is also important to the prenatal development of normal neurological pathways for the control of ventilation. The importance of NMDA receptors to both normal breathing and stress responses is demonstrated by recent observations of antenatal effects of disturbances to the NMDA receptor which disrupts normal breathing as well as causing reduced ventilatory responses during stress in newborns. These characteristics fit with the known NMDA influences on neuronal development and plasticity. The methods used to evaluate these functions have mainly included pharmacological agents for activation (agonists) or depression (antagonists) of NMDA receptors. NMDA receptor expression has also been measured histologically, and more recently knockout animal models have been used to provide additional functional information.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908286     DOI: 10.1016/j.resp.2005.03.009

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  11 in total

1.  Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.

Authors:  Yan Zhang; Gang Liu; Mengdi Jiang; Weibi Chen; Yanbo He; Yingying Su
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

Review 2.  Glutamatergic autoencephalitides: an emerging field.

Authors:  Jessica A Panzer; Amy J Gleichman; David R Lynch
Journal:  J Neural Transm (Vienna)       Date:  2014-01-09       Impact factor: 3.575

3.  Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.

Authors:  Cara A Mosley; Timothy M Acker; Kasper B Hansen; Praseeda Mullasseril; Karen T Andersen; Phuong Le; Kimberly M Vellano; Hans Bräuner-Osborne; Dennis C Liotta; Stephen F Traynelis
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

4.  Postnatal development of N-methyl-D-aspartate receptor subunits 2A, 2B, 2C, 2D, and 3B immunoreactivity in brain stem respiratory nuclei of the rat.

Authors:  Q Liu; M T T Wong-Riley
Journal:  Neuroscience       Date:  2010-09-29       Impact factor: 3.590

Review 5.  Serotonin and NMDA receptors in respiratory long-term facilitation.

Authors:  Liming Ling
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

6.  Successful Use of Ketamine for Central Neurogenic Hyperventilation: A Case Report.

Authors:  G Morgan Jones; Adam L Wiss; Nitin Goyal; Jason J Chang
Journal:  Neurohospitalist       Date:  2017-03-06

7.  S-Methadone augments R-methadone induced respiratory depression in the neonatal guinea pig.

Authors:  Daniel A N Silverman; Rosemary T Nettleton; Katherine B Spencer; Michael Wallisch; George D Olsen
Journal:  Respir Physiol Neurobiol       Date:  2009-09-08       Impact factor: 1.931

8.  MicroRNA expression profile in intrauterine hypoxia-induced pulmonary hypoplasia in rats.

Authors:  Huiyi Huo; Ziqiang Luo; Mingjie Wang; Xiaohe Yu; Zhengchang Liao; Xiaocheng Zhou; Shaojie Yue
Journal:  Exp Ther Med       Date:  2014-06-20       Impact factor: 2.447

9.  Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma: two cases report and anesthesia considerations.

Authors:  Haiyang Liu; Minyu Jian; Fa Liang; Hongli Yue; Ruquan Han
Journal:  BMC Anesthesiol       Date:  2015-10-16       Impact factor: 2.217

10.  Levofloxacin-associated Encephalopathy with Severe Hyperventilation.

Authors:  Mieko Sugiura; Koichi Shibata; Satoshi Saito; Yoshiko Nishimura; Hiroshi Sakura
Journal:  Intern Med       Date:  2019-02-01       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.